Related Experiment Videos
Immunologic priming with recombinant hepatitis A virus capsid proteins produced in Escherichia coli
1Department of Clinical Immunology, Burroughs Wellcome Company, Research Triangle Park, North Carolina 27709.
Journal of Virology
|May 1, 1991
Abstract:
Hepatitis A virus capsid proteins (VP0, VP3, and VP1) have been synthesized in Escherichia coli for use in antigenic and immunogenic analyses. Rabbits immunized with each of these individual recombinant capsid proteins developed a rapid neutralizing antibody response when subsequently challenged with a subimmunogenic dose of whole virus.